238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
View analysts' price targets and recommendations, and compare them with competitors.
$187.00
Analysts expect the stock price to decrease by 22.34%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
60.27B
The estimated revenue has decreased from the previous period.
24.00B
The estimated EBITDA has increased from the previous period.
1.45
The estimated EPS has increased from the previous period.
15.78B
The estimated net income has increased from the previous period.
18.71B
The estimated EBIT has increased from the previous period.
18.75B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
182.53B
Revenue has increased from the previous period.
12.77%
Revenue growth rate has increased from the previous period.
61.91B
EBITDA has increased from the previous period.
33.92%
EBITDA margin has increased from the previous period.
48.22B
EBIT has increased from the previous period.
26.42%
EBIT margin has increased from the previous period.
13.70B
Depreciation has increased from the previous period.
136.69B
Total cash has increased from the previous period.
74.89%
Cash percentage has increased from the previous period.
31.38B
Receivables have increased from the previous period.
17.19%
Receivables percentage has increased from the previous period.
728.00M
Inventories have decreased from the previous period.
0.40%
Inventory percentage has decreased from the previous period.
5.59B
Accounts payable has increased from the previous period.
3.06%
Payables percentage has decreased from the previous period.
-22.28B
Capital expenditure has decreased from the previous period.
-12.21%
CapEx percentage has decreased from the previous period.
9.08%
WACC is unchanged from the previous period.
9.14%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.03
Beta is unchanged from the previous period.
12.72B
Diluted shares outstanding is unchanged from the previous period.
28.50B
Total debt is unchanged from the previous period.
2.49T
Total equity is unchanged from the previous period.
2.51T
Total capital is unchanged from the previous period.
1.13%
Debt weighting is unchanged from the previous period.
98.87%
Equity weighting is unchanged from the previous period.
40.38B
EBIAT has increased from the previous period.
28.21B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
2.32T
Terminal value is unchanged from the previous period.
1.82T
Enterprise value has increased from the previous period.
4.46B
Net debt is unchanged from the previous period.
1.81T
Equity value has increased from the previous period.
142.34
Equity value per share has increased from the previous period.
